The Joint (JYNT)
(Delayed Data from NSDQ)
$14.00 USD
-0.29 (-2.03%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $14.07 +0.07 (0.50%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth F Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
JYNT 14.00 -0.29(-2.03%)
Will JYNT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for JYNT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JYNT
Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine
Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues
JYNT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alcon (ALC) Inks Buyout Deal to Expand Its Glaucoma Portfolio
Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY
Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout
Other News for JYNT
Analysts Are Bullish on Top Healthcare Stocks: Joint (JYNT), Stereotaxis (STXS)
The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts
Joint Corp. signs agreement engaging Capstone Partners
The Joint Corp. to Participate in Upcoming Investor Conferences
Joint Corp. price target raised by $8 at B. Riley, here's why